首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1608891

化疗市场：依药物、癌症类型、给药途径、通路、地区分类

Chemotherapy Market, By Drugs, By Cancer Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2024年11月25日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年化疗市场规模为108.7亿美元，预计2031年将达183.5亿美元，2024年至2031年复合年增长率为7.8%。

分析范围		分析详情
基准年	2023年	市场规模（2024年）	108.7亿美元
实际资料	2019-2023	预测期	2024-2031
预测期复合年增长率（2024-2031）	7.80%	预计金额（2031年）	183.5亿美元

图：2024 年化疗市场占有率（%），依地区划分

化疗是一种癌症治疗方法，使用一种或多种抗癌药物作为标准化化疗方案的一部分。化疗药物的作用是减缓或阻止癌细胞的生长，癌细胞的生长、分裂和扩散速度比正常细胞更快。化疗用于治疗多种类型的癌症，包括乳癌、肺癌、大肠癌、淋巴瘤、白血病、膀胱癌、睪丸癌和卵巢癌。化疗通常透过静脉注射，但也可以口服或局部给药。化疗通常按週期进行，每个治疗期之后都有一个恢復期，在此期间身体会产生健康的新细胞。副作用因所用药物、剂量和患者而异，但可能包括疲劳、食慾不振、噁心、呕吐、脱髮、口腔炎和免疫力下降。

市场动态：

各种类型癌症盛行率的上升和老年人口的增加（越来越容易罹患癌症）是预计未来几年推动化疗市场成长的关键因素。此外，对标靶药物治疗和个人化医疗的需求不断增长、药物传输系统的技术进步以及临床开发中新型化疗药物的强大管道可能会进一步推动市场扩张。然而，化疗药物的副作用、抗药性风险、抗癌药物高成本、新兴国家缺乏医疗基础设施和意识等可能会在整个预测期内在一定程度上抑制市场。降低毒性、提高疗效的创新药物输送系统的开发以及抗癌药物的靶向输送为该市场的参与企业带来了广阔的机会。

本研究的主要特点

本报告详细分析了全球化疗市场，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR，%）。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
基于公司亮点、产品系列、主要亮点、业绩和策略等参数的全球化疗市场主要企业的概况。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、产品创新、市场扩张和行销策略做出明智的决策。
全球化疗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球化疗市场的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	10.87 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	7.80%	2031 Value Projection:	18.35 Bn

Chemotherapy is a type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen. Chemotherapy drugs work by slowing or stopping the growth of cancer cells which grow, divide, and spread more rapidly than normal cells. Chemotherapy is used to treat many types of cancers including breast cancer, lung cancer, colorectal cancer, lymphoma, leukemia, bladder cancer, testicular cancer, ovarian cancer, and others. It is often given intravenously but can also be given by mouth or topically. Chemotherapy is usually given in cycles with each period of treatment followed by a recovery period to allow the body to build healthy new cells. Side effects depend on the specific drugs used, dosage, and the patient but can include fatigue, loss of appetite, nausea, vomiting, hair loss, mouth sores, and lowered immunity.

Market Dynamics:

The rising prevalence of various types of cancers and the growing geriatric population, which is increasingly susceptible to developing cancer, are significant factors expected to drive the growth of the chemotherapy market in the coming years. Additionally, the increasing demand for targeted drug therapies and personalized medicine, along with technological advancements in drug delivery systems and a strong pipeline of novel chemotherapy agents in clinical development, will further enhance market expansion. However, the toxicity and side effects associated with chemotherapy drugs, risk of drug resistance, high costs of cancer drugs, and lack of healthcare infrastructure and awareness in developing countries are likely to restrain the market to a certain extent over the forecast period. Development of innovative drug delivery systems to reduce toxicity and improve efficacy and targeted delivery of anti-cancer drugs hold promising opportunities for players in this market.

Key Features of the Study:

This report provides in-depth analysis of the global chemotherapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global chemotherapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Novartis AG, GSK plc., Sanofi, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH., AbbVie Inc., Merck & Co., Inc., Eureka Therapeutics, Inc., Verismo Therapeutics, Inc., Bayer AG, and Autolus Therapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global chemotherapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chemotherapy market

Market Segmentation

By Drugs Insights (Revenue, USD Bn, 2019 - 2031)
- Alkylating agents
- Antimetabolites
- Anti-tumor antibiotics
- Others
By Cancer Type Insights (Revenue, USD Bn, 2019 - 2031)
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Blood Cancer
- Liver Cancer
- Others
By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Parenteral
- Others
By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Bristol-Myers Squibb Company
- AstraZeneca
- Pfizer Inc.
- Novartis AG
- GSK plc.
- Sanofi
- Amgen Inc.
- Gilead Sciences, Inc.
- Boehringer Ingelheim International GmbH.
- AbbVie Inc.
- Merck & Co., Inc.
- Eureka Therapeutics, Inc.
- Verismo Therapeutics, Inc.
- Bayer AG
- Autolus Therapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Chemotherapy Market, By Drugs
- Chemotherapy Market, By Cancer Type
- Chemotherapy Market, By Route of Administration
- Chemotherapy Market, By Distribution Channel
- Chemotherapy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Epidemiology

4. Global Chemotherapy Market, By Drugs, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Alkylating agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antimetabolites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Anti-tumor antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Chemotherapy Market, By Cancer Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Blood Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Chemotherapy Market, By Route of Administration, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Chemotherapy Market, By Distribution Channel, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Chemotherapy Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
Amgen Inc.
Gilead Sciences, Inc.
Boehringer Ingelheim International GmbH.
AbbVie Inc.
Merck & Co., Inc.
Eureka Therapeutics, Inc.
Verismo Therapeutics, Inc.
Bayer AG
Autolus Therapeutics

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

化疗市场：依药物、癌症类型、给药途径、通路、地区分类